{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:22:12Z","timestamp":1793996532105,"version":"4.8.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.pnpbp.2008.12.004","type":"journal-article","created":{"date-parts":[[2008,12,25]],"date-time":"2008-12-25T05:13:36Z","timestamp":1230182016000},"page":"169-180","source":"Crossref","is-referenced-by-count":281,"title":["Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review"],"prefix":"10.1016","volume":"33","author":[{"given":"William","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro V.","family":"Mendlowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Marques-Portella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Kinrys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo F.","family":"Fontenelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Marmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Figueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2008.12.004_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.yic.0000182116.49887.ae","article-title":"Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study","volume":"21","author":"Ahearn","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib2","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jclinepi.2005.04.003","article-title":"Case reports and case series from Lancet had significant impact on medical literature","volume":"58","author":"Albrecht","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3956(02)00058-4","article-title":"Psychopharmacological treatment in PTSD: a critical review","volume":"36","author":"Albucher","year":"2002","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib4","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00003495-200464040-00004","article-title":"SSRIs versus non-SSRIs in post-traumatic stress disorder\u2014an update with recommendations","volume":"64","author":"Asnis","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib6","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.4088\/JCP.v65n1216","article-title":"Remission rates in patients with anxiety disorders treated with paroxetine","volume":"65","author":"Ballenger","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biopsych.2004.11.039","article-title":"Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder","volume":"57","author":"Bartzokis","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-244X-4-24","article-title":"Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder","volume":"4","author":"Berlant","year":"2004","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4088\/JCP.v63n0104","article-title":"Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report","volume":"63","author":"Berlant","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib10","first-page":"187","article-title":"A clinical rating scale for assessing current and lifetime PTSD: the CAPS 1","volume":"18","author":"Blake","year":"1990","journal-title":"Behav Ther"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib11","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.283.14.1837","article-title":"Efficacy and safety of sertraline treatment of posttraumatic stress disorder\u2014a randomized controlled trial","volume":"283","author":"Brady","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib12","first-page":"236","article-title":"Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment","volume":"51","author":"Braun","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.4088\/JCP.v65n1120","article-title":"Treatment of posttraumatic stress disorder with phenytoin: an open-label pilot study","volume":"65","author":"Bremner","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib14","series-title":"Trauma symptoms checklist for children","author":"Briere","year":"1996"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0006-3223(95)00314-2","article-title":"Positive symptoms of psychosis in posttraumatic stress disorder","volume":"39","author":"Butler","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004850-200107000-00003","article-title":"Olanzapine in the treatment of post-traumatic stress disorder: a pilot study","volume":"16","author":"Butterfield","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2710.2007.00846.x","article-title":"Augmentation strategies for treatment-resistant depression: a literature review","volume":"32","author":"Carvalho","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00004714-199910000-00023","article-title":"Cyproheptadine treatment of nightmares associated with posttraumatic stress disorder","volume":"19","author":"Clark","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1024797014210","article-title":"Divalproex in posttraumatic stress disorder: an open-label clinical trial","volume":"12","author":"Clark","year":"1999","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1520-6394(1999)9:3<135::AID-DA6>3.0.CO;2-A","article-title":"Further psychometric assessment of the TOP-8: a brief interview-based measure of PTSD","volume":"9","author":"Connor","year":"1999","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004850-200109000-00005","article-title":"SPRINT: a brief global assessment of post-traumatic stress disorder","volume":"16","author":"Connor","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1192\/bjp.175.1.17","article-title":"Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study","volume":"175","author":"Connor","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00213-005-0265-3","article-title":"Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment","volume":"184","author":"Connor","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1192\/bjp.150.5.685","article-title":"Lithium in the treatment of aggression in mentally handicapped patients. A double-blind trial","volume":"150","author":"Craft","year":"1987","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0091-6773(75)91459-5","article-title":"Kindling in hypothalamus and transfer to the ipsilateral amygdala","volume":"15","author":"Cullen","year":"1975","journal-title":"Behav Biol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7205\/MILMED.170.6.513","article-title":"Clinical case series: the use of prazosin for combat-related recurrent nightmares among Operation Iraqi Freedom combat veterans","volume":"170","author":"Daly","year":"2005","journal-title":"Mil Med"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/01.jcp.0000138771.46353.59","article-title":"Adjunctive risperidone treatment in combat veterans with chronic PTSD","volume":"24","author":"David","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/da.20187","article-title":"Adjunctive risperidone treatment and sleep symptoms in combat veterans with chronic PTSD","volume":"23","author":"David","year":"2006","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1017\/S0033291796004229","article-title":"Assessment of a new self-rating scale for post-traumatic stress disorder","volume":"27","author":"Davidson","year":"1997","journal-title":"Psychol Med"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004714-199802000-00020","article-title":"Fluvoxamine in civilians with PTSD","volume":"18","author":"Davidson","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib33","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1176\/appi.ajp.158.12.1974","article-title":"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study","volume":"158","author":"Davidson","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib34","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archpsyc.63.10.1158","article-title":"Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial","volume":"63","author":"Davidson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/JCP.0b013e31802e5115","article-title":"The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder","volume":"27","author":"Davidson","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib36","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0006-3223(02)01507-X","article-title":"The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy","volume":"52","author":"Davis","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/13651500500305564","article-title":"Divalproex for the treatment of posttraumatic stress disorder: a retrospective chart review","volume":"9","author":"Davis","year":"2005","journal-title":"Int J Psychiatr Clin Pract"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/JCP.0b013e318160f83b","article-title":"Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population","volume":"28","author":"Davis","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1196\/annals.1364.056","article-title":"Noradrenergic signaling in the amygdala contributes to the reconsolidation of fear memory. treatment implications for PTSD","volume":"1071","author":"Deebie","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib40","series-title":"The SCL-9OR: scoring, administration and procedures manual: II","author":"Derogatis","year":"1977"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/1520-6394(2000)11:4<187::AID-DA9>3.0.CO;2-C","article-title":"Risperidone in the treatment of acute stress disorder in physically traumatized in-patients","volume":"11","author":"Eidelman","year":"2000","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib42","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archpedi.1988.02150110122036","article-title":"Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study","volume":"142","author":"Famularo","year":"1988","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib43","first-page":"361","article-title":"Valproate in combat-related posttraumatic-stress-disorder","volume":"52","author":"Fesler","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/070674370304800416","article-title":"Quetiapine reduces flashbacks in chronic posttraumatic stress disorder","volume":"48","author":"Filteau","year":"2003","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jts.2490060405","article-title":"Reliability and validity of a brief instrument for assessing posttraumatic stress disorder","volume":"6","author":"Foa","year":"1993","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jts.2490080110","article-title":"Lithium for irritability in posttraumatic-stress-disorder","volume":"8","author":"Forster","year":"1995","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib47","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1037\/1040-3590.4.1.92","article-title":"Clinical validation of the Quality of Life Inventory: a measure of life satisfaction for use in treatment planning and outcome assessment","volume":"4","author":"Frisch","year":"1992","journal-title":"Psychol Assess"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib48","first-page":"390","article-title":"Treatment of recent trauma survivors with benzodiazepines: a prospective study","volume":"57","author":"Gelpin","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib49","first-page":"255","article-title":"A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder","volume":"30","author":"Glover","year":"1993","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0011-393X(03)00003-1","article-title":"An open-label pilot study of divalproex sodium for posttraumatic stress disorder related to childhood abuse","volume":"64","author":"Goldberg","year":"2003","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib51","series-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"12","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/10401230109148960","article-title":"Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy","volume":"13","author":"Hamner","year":"2001","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-200302000-00003","article-title":"Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy","volume":"23","author":"Hamner","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004850-200301000-00001","article-title":"Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms","volume":"18","author":"Hamner","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib56","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1017\/S1092852900022380","article-title":"Treatment-resistant posttraumatic stress disorder: strategies for intervention","volume":"9","author":"Hamner","year":"2004","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib57","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/00004583-199609000-00022","article-title":"Clonidine for posttraumatic stress disorder in preschool children","volume":"35","author":"Harmon","year":"1996","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib58","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0006-3223(99)00011-6","article-title":"A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder","volume":"45","author":"Hertzberg","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib59","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/msj.20041","article-title":"Anxiety disorders: a comprehensive review of pharmacotherapies","volume":"75","author":"Hoffman","year":"2008","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib60","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00002826-200207000-00006","article-title":"Antiepileptic drugs in posttraumatic stress disorder","volume":"25","author":"Iancu","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib61","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1034\/j.1600-0447.2003.00065.x","article-title":"Olanzapine in the treatment-resistant, combat-related PTSD\u2014a series of case reports","volume":"107","author":"Jakovljevic","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib62","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1017\/S1092852900010063","article-title":"Lamotrigine in psychiatry: pharmacology and therapeutics","volume":"10","author":"Jefferson","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00925945","article-title":"Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA)","volume":"131","author":"Kalimi","year":"1994","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0361-9230(00)00251-3","article-title":"Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. implications for depression","volume":"52","author":"Kaminska","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib66","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","article-title":"Posttraumatic stress disorder in the National Comorbidity Survey","volume":"52","author":"Kessler","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib67","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4088\/JCP.v67n0206","article-title":"Levetiracetam for treatment-refractory posttraumatic stress disorder","volume":"67","author":"Kinrys","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib68","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/milmed\/150.7.378","article-title":"Low-dose lithium-carbonate in the treatment of post traumatic stress disorder","volume":"150","author":"Kitchner","year":"1985","journal-title":"Mil Med"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib69","series-title":"Posttraumatic stress disorder: psychological and biological sequelae","first-page":"97","article-title":"Propranolol and clonidine in the treatment of chronic posttraumatic stress of war","author":"Kolb","year":"1984"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib70","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4088\/JCP.v66n0716","article-title":"Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial","volume":"66","author":"Kozaric-Kovacic","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib71","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.yic.0000185021.48279.00","article-title":"Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans","volume":"21","author":"Lambert","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib72","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00788510","article-title":"Assessing impairment in patients with panic disorder: the Sheehan Disability Scale","volume":"27","author":"Leon","year":"1992","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib73","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1004684223522","article-title":"Successfully treating aggression in mentally ill prison inmates","volume":"71","author":"Lewis","year":"2000","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib74","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/jcp.0b013e31815a43ee","article-title":"A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder","volume":"27","author":"Lindley","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib75","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0033-3182(86)72590-5","article-title":"Preliminary study of carbamazepine in post-traumatic stress disorder","volume":"27","author":"Lipper","year":"1986","journal-title":"Psychosomatics"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib76","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00004583-199506000-00008","article-title":"Carbamazepine for Ptsd","volume":"34","author":"Looff","year":"1995","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib77","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hup.395","article-title":"Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study","volume":"17","author":"Lubin","year":"2002","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib78","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00004714-199604000-00013","article-title":"Vigabatrin and posttraumatic stress disorder","volume":"16","author":"Macleod","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib79","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1176\/appi.ajp.158.12.1982","article-title":"Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study","volume":"158","author":"Marshall","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib80","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1176\/appi.ajp.158.9.1467","article-title":"Comorbidity, impairment, and suicidality in subthreshold PTSD","volume":"158","author":"Marshall","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib81","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4088\/JCP.v63n1214h","article-title":"Hypnotic medication in the aftermath of trauma","volume":"63","author":"Mellman","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib82","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4088\/JCP.v69n0611","article-title":"Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection","volume":"69","author":"Mohamed","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib83","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004714-200304000-00012","article-title":"Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder","volume":"23","author":"Monnelly","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib84","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/jcp.0b013e318059361a","article-title":"The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence","volume":"27","author":"Mula","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib85","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1023\/A:1011100420978","article-title":"Fluvoxamine and sleep disturbances in posttraumatic stress disorder","volume":"14","author":"Neylan","year":"2001","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib86","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1176\/appi.ajp.163.12.2186","article-title":"No improvement of posttraumatic stress disorder symptoms with guanfacine treatment","volume":"163","author":"Neylan","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib87","first-page":"24","article-title":"The psychobiology of posttraumatic stress disorder","volume":"61","author":"Nutt","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib88","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.jcp.0000106234.36344.a4","article-title":"Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study","volume":"24","author":"Otte","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib89","first-page":"97","article-title":"Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling","volume":"24","author":"Overall","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib90","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004850-200609000-00005","article-title":"Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women","volume":"21","author":"Padala","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib91","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0891988703256050","article-title":"Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder","volume":"16","author":"Peskind","year":"2003","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib92","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00004850-200111000-00003","article-title":"Olanzapine treatment for post-traumatic stress disorder: an open-label study","volume":"16","author":"Petty","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib93","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00004714-200202000-00021","article-title":"Valproate therapy for chronic, combat-induced posttraumatic stress disorder","volume":"22","author":"Petty","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib94","first-page":"451","article-title":"Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder","volume":"175","author":"Pivac","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib95","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4088\/JCP.v61n0208","article-title":"The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases","volume":"61","author":"Raskind","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib96","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4088\/JCP.v63n0705","article-title":"Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder","volume":"63","author":"Raskind","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib97","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.ajp.160.2.371","article-title":"Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study","volume":"160","author":"Raskind","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib98","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.biopsych.2006.06.032","article-title":"A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with posttraumatic stress disorder","volume":"61","author":"Raskind","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib99","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300432","article-title":"An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood symptoms in women with PTSD","volume":"29","author":"Rasmusson","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib100","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4088\/JCP.v65n1204","article-title":"A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women","volume":"65","author":"Reich","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib101","first-page":"4","article-title":"Preclinical pharmacology of neuroleptics: focus on new generation compounds","volume":"57","author":"Richelson","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib102","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.jcp.0000169624.37819.60","article-title":"Quetiapine improves sleep disturbances in combat veterans with PTSD\u2014sleep data from a prospective, open-label study","volume":"25","author":"Robert","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib103","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.v69n0402","article-title":"Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder","volume":"69","author":"Rothbaum","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib104","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4088\/JCP.v67n0323b","article-title":"3-acetyl-7-oxo-dehydroepiandrosterone for healing treatment-resistant posttraumatic stress disorder in women: 5 case reports","volume":"67","author":"Sageman","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib105","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archpsyc.57.10.925","article-title":"Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders","volume":"57","author":"Sapolsky","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jad.2006.05.023","article-title":"Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression","volume":"96","author":"Schaffer","year":"2006","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib107","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1176\/appi.ps.55.5.519","article-title":"Current concepts in pharmacotherapy for posttraumatic stress disorder","volume":"55","author":"Schoenfeld","year":"2004","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib108","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1196\/annals.1364.007","article-title":"Amygdala, medial prefrontal cortex, and hippocampal function in PTSD","volume":"1071","author":"Shin","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib109","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4088\/PCC.v05n0203","article-title":"Chronic sleep disruption and the reexperiencing cluster of posttraumatic stress disorder symptoms are improved by olanzapine: brief review of the literature and a case-based series","volume":"5","author":"States","year":"2003","journal-title":"Primary Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib110","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.jcp.0000186901.79861.e2","article-title":"A preliminary case series on the use of quetiapine for posttraumatic stress disorder in juveniles within a youth detention center","volume":"25","author":"Stathis","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib111","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1176\/appi.ajp.159.10.1777","article-title":"Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study","volume":"159","author":"Stein","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib112","first-page":"CD 002795","article-title":"Pharmacotherapy for post traumatic stress disorder (PTSD)","volume":"1","author":"Stein","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib113","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10578-007-0055-8","article-title":"Divalproex sodium for the treatment of PTSD and conduct disordered youth: a pilot randomized controlled clinical trial","volume":"38","author":"Steiner","year":"2007","journal-title":"Child Psychiatry Hum Dev"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib114","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00004714-200202000-00013","article-title":"The alpha 1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder","volume":"22","author":"Taylor","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.biopsych.2005.09.023","article-title":"Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder","volume":"59","author":"Taylor","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib116","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biopsych.2007.07.001","article-title":"Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study","volume":"63","author":"Taylor","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib117","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4088\/JCP.v62n1105","article-title":"Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial","volume":"62","author":"Tucker","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib118","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4088\/JCP.v68n0204","article-title":"Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study","volume":"68","author":"Tucker","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib119","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0278-5846(84)90052-6","article-title":"Factors associated with a good response to lithium in aggressive mentally handicapped subjects","volume":"8","author":"Tyrer","year":"1984","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib120","first-page":"S3","article-title":"Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder","volume":"161","author":"Ursano","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib121","series-title":"Clinical practice guideline No 5: depression in primary care, Vol 2: treatment of major depression","first-page":"71","article-title":"Depression guideline panel","author":"US Department of Health and Human Services","year":"1993"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib122","first-page":"417","article-title":"Endogenous opioids, stress induced analgesia, and posttraumatic stress disorder","volume":"25","author":"van der Kolk","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib123","first-page":"517","article-title":"Fluoxetine in posttraumatic stress disorder","volume":"55","author":"van der Kolk","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib124","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/1097-4679(199103)47:2<179::AID-JCLP2270470202>3.0.CO;2-P","article-title":"The PTSD interview: rationale, description, reliability, and concurrent validity of a DSM-III-based technique","volume":"47","author":"Watson","year":"1991","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib125","series-title":"Paper present at the Annual Meeting of International Society for Traumatic Stress Studies","article-title":"The PTSD Checklist (PCL): reliability, validity, and diagnostic utility","author":"Weathers","year":"1993"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib126","series-title":"Assessing psychological trauma and PTSD: a practitioner's handbook","first-page":"399","article-title":"The impact of event scale-revised","author":"Weiss","year":"1997"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib127","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/B:COTR.0000021540.15135.45","article-title":"Benzodiazepine use associated with decreased memory for psychoeducation material in cognitive behavioral therapy for panic disorder","volume":"28","author":"Westra","year":"2004","journal-title":"Cogn Ther Res"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.jcp.0000116650.91923.1d","article-title":"Clozapine treatment of adolescents with posttraumatic stress disorder and psychotic symptoms","volume":"24","author":"Wheatley","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib129","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0006-3223(88)90011-X","article-title":"Posttraumatic stress disorder in Vietnam veterans clinical and EEG findings\u2014possible therapeutic effects of carbamazepine","volume":"23","author":"Wolf","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.12.004_bib130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00004714-200204000-00013","article-title":"Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder","volume":"22","author":"Zohar","year":"2002","journal-title":"J Clin Psychopharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608003771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608003771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T13:49:54Z","timestamp":1558014594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584608003771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":129,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0278584608003771"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2008.12.004","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}